1. Современная терапия рака молочной железы: от тамоксифена до т-клеточной инженерии

    Shevchenko, J. A., Kuznetsova, M. S., Khristin, A. A., Sidorov, S. V. & Sennikov, S. V., 2022, In: Siberian Journal of Oncology. 21, 5, p. 109-122 14 p., 12.

    Research output: Contribution to journalArticlepeer-review

  2. Получение дендритных клеток мышей in vitro с помощью Flt3-L и их характеристика

    Tereshchenko, V. P., Bulygin, A. S., Zavodskii, R. Y., Kulikova, E. V. & Sennikov, S. V., 2020, In: Immunologiya. 41, 3, p. 215-226 12 p.

    Research output: Contribution to journalArticlepeer-review

  3. Пентоксифиллин способствует повышению in vitro противоопухлевой цитотоксичности Т-клеток больных раком молочной железы

    Kuznetsova, M. S., Shevchenko, Y. A., Khantakova, Y. N., Khristin, A. A., Obleukhova, I. A., Silkov, A. N., Sidorov, S. V. & Sennikov, S. V., 2021, In: Medical Immunology (Russia). 23, 4, p. 785-790 6 p., 26.

    Research output: Contribution to journalArticlepeer-review

  4. Особенности количественной экспрессии рецепторов checkpoint-молекул PD-1 и TIM-3 на CD4+ и CD8+Т-клетках при раке молочной железы разной степени прогрессии

    Shevchenko, Y. A., Kuznetsova, M. S., Khantakova, Y. N., Obleukhova, I. A., Khristin, A. A., Sidorov, S. V. & Sennikov, S. V., 2021, In: Medical Immunology (Russia). 23, 4, p. 865-870 6 p., 38.

    Research output: Contribution to journalArticlepeer-review

  5. TNF receptors profile changes on cytotoxic T-cells subsets in rheumatoid arthritis are associated with effective treatment

    Alshevskaya, A., Lopatnikova, J., Zhukova, J., Kireev, F., Chumasova, O., Shkaruba, N., Sizikov, A., Gladkikh, V. & Sennikov, S., Jun 2020, In: Annals of the rheumatic diseases. 79, p. 1337-1338 2 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  6. TNF-ALPHA RECEPTORS EXPRESSION ON IMMUNE CELLS IN ATOPIC DERMATITIS IS ASSOCIATED WITH DISEASE ACTIVITY

    Alshevskaya, A. A., Lopatnikova, J., Krugleeva, O., Nepomnyschih, V., Lukinov, V. & Sennikov, S., Nov 2016, In: Cytokine. 87, p. 69-69 1 p.

    Research output: Contribution to journalMeeting Abstractpeer-review

  7. The Role of Tumor-Associated Antigen HER2/neu in Tumor Development and the Different Approaches for Using It in Treatment: Many Choices and Future Directions

    Alrhmoun, S. & Sennikov, S., 14 Dec 2022, In: Cancers. 14, 24, 6173.

    Research output: Contribution to journalReview articlepeer-review

  8. The murine DCs transfected with DNA-plasmid encoding CCR9 demonstrate the increased migration to CCL25 and thymic cells in vitro and to the thymus in vivo

    Tereshchenko, V., Bulygin, A., Zavodskii, R., Maksyutov, A., Kurilin, V., Fisher, M., Semenyuk, N., Aladev, S. & Sennikov, S., Jun 2021, In: Cytokine. 142, 155473.

    Research output: Contribution to journalArticlepeer-review

  9. The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy?

    Alsalloum, A., Shevchenko, J. A. & Sennikov, S., 15 Mar 2023, In: Cancers. 15, 6, 1779.

    Research output: Contribution to journalReview articlepeer-review

  10. The Effects of Immunosuppressive Factors on Primary Dendritic Cells from C57BL/6 and CBA Mice

    Kurilin, V. V., Khantakova, J. N., Tereschenko, V. P., Lopatnikova, J. A., Obleukhova, I. A. & Sennikov, S. V., 1 Jan 2019, In: Journal of Immunology Research. 2019, p. 7029726 12 p., 7029726.

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 3 4 5 Next

ID: 16345732